[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

UA106724C2 - Спосіб отримання заміщених піримідинових похідних - Google Patents

Спосіб отримання заміщених піримідинових похідних

Info

Publication number
UA106724C2
UA106724C2 UAA201100983A UAA201100983A UA106724C2 UA 106724 C2 UA106724 C2 UA 106724C2 UA A201100983 A UAA201100983 A UA A201100983A UA A201100983 A UAA201100983 A UA A201100983A UA 106724 C2 UA106724 C2 UA 106724C2
Authority
UA
Ukraine
Prior art keywords
preparation
pyrimidine derivatives
substituted pyrimidine
intermediates
synthesis
Prior art date
Application number
UAA201100983A
Other languages
English (en)
Russian (ru)
Inventor
Серджіо Ческо-Канчіан
Хунфен Чень
Джеффрі С. Грімм
Неєлакандха С. Мані
Крістофер М. Мейпс
Девід К. Палмер
Деніел Дж. Піппел
Кірк Л. Соргі
Тун Сяо
Original Assignee
Янссен Фармацевтика Нв
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41464882&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA106724(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Янссен Фармацевтика Нв filed Critical Янссен Фармацевтика Нв
Publication of UA106724C2 publication Critical patent/UA106724C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/20—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
    • C07C211/22—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton containing at least two amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Даний винахід спрямований на створення способів одержання заміщених піримідинових похідних, що можуть знайти застосування як проміжні сполуки при синтезі модуляторів гістамінового рецептора H, а також на нові проміжні сполуки в синтезі модуляторів Н.
UAA201100983A 2008-06-30 2009-06-29 Спосіб отримання заміщених піримідинових похідних UA106724C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7675208P 2008-06-30 2008-06-30
PCT/US2009/049027 WO2010002774A1 (en) 2008-06-30 2009-06-29 Process for the preparation of substituted pyrimidine derivatives

Publications (1)

Publication Number Publication Date
UA106724C2 true UA106724C2 (uk) 2014-10-10

Family

ID=41464882

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201100983A UA106724C2 (uk) 2008-06-30 2009-06-29 Спосіб отримання заміщених піримідинових похідних

Country Status (36)

Country Link
US (6) US8309720B2 (uk)
EP (5) EP2924025A1 (uk)
JP (1) JP5416768B2 (uk)
KR (1) KR101675354B1 (uk)
CN (1) CN102137672B (uk)
AR (1) AR072396A1 (uk)
AU (1) AU2009267156B2 (uk)
BR (1) BRPI0913644A2 (uk)
CA (1) CA2729733C (uk)
CO (1) CO6341560A2 (uk)
CY (1) CY1116134T1 (uk)
DK (1) DK2310012T3 (uk)
EA (1) EA019361B1 (uk)
EC (1) ECSP11010745A (uk)
ES (1) ES2538135T3 (uk)
HK (4) HK1156857A1 (uk)
HR (1) HRP20150576T1 (uk)
HU (1) HUE024949T2 (uk)
IL (4) IL210214A (uk)
JO (1) JO3043B1 (uk)
ME (1) ME02154B (uk)
MX (1) MX2011000080A (uk)
MY (1) MY150601A (uk)
NI (1) NI201000232A (uk)
NZ (1) NZ590170A (uk)
PE (1) PE20110163A1 (uk)
PL (1) PL2310012T3 (uk)
PT (1) PT2310012E (uk)
RS (1) RS53985B1 (uk)
SI (1) SI2310012T1 (uk)
SV (1) SV2011003788A (uk)
TW (3) TWI498326B (uk)
UA (1) UA106724C2 (uk)
UY (1) UY31949A (uk)
WO (1) WO2010002774A1 (uk)
ZA (1) ZA201100759B (uk)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2348829T3 (es) 2006-03-31 2010-12-15 Janssen Pharmaceutica Nv Benzimidazol-2-il-pirimidinas y pirazinas moduladoras del receptor h4 de histamina.
US9371311B2 (en) 2008-06-30 2016-06-21 Janssen Pharmaceutica Nv Benzoimidazol-2-yl pyrimidine derivatives
NZ590170A (en) 2008-06-30 2012-04-27 Janssen Pharmaceutica Nv Process for the preparation of substituted pyrimidine derivatives
JP5574294B2 (ja) * 2010-11-04 2014-08-20 独立行政法人科学技術振興機構 光磁気記録媒体及び光磁気記録方法
EA201591648A1 (ru) 2013-03-06 2016-02-29 Янссен Фармацевтика Нв Бензимидазол-2-ил-пиримидиновые модуляторы рецептора гистамина h4
SG11201608114QA (en) * 2014-03-28 2016-11-29 Kaneka Corp Method for producing tri-carbobenzoxy-arginine
SG11201903871TA (en) 2016-11-03 2019-05-30 Bristol Myers Squibb Co Substituted bicycle heterocyclic derivatives useful as romk channel inhibitors

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3005852A (en) 1959-12-22 1961-10-24 Gen Aniline & Film Corp Production of sulfoxides and sulfones
US3931195A (en) * 1971-03-03 1976-01-06 Mead Johnson & Company Substituted piperidines
US4191828A (en) * 1976-04-14 1980-03-04 Richardson-Merrell Inc. Process for preparing 2-(2,2-dicyclohexylethyl)piperidine
US4190601A (en) * 1978-05-31 1980-02-26 Union Carbide Corporation Production of tertiary amines by reductive alkylation
JPS5942396A (ja) * 1982-09-02 1984-03-08 Ishihara Sangyo Kaisha Ltd リン酸アミド誘導体およびそれらを含有する殺虫、殺ダニ、殺線虫剤
JPS6130576A (ja) 1984-07-24 1986-02-12 Ube Ind Ltd ２−アミノ−５−シアノピリミジンの製法
CA2144762A1 (en) * 1992-10-14 1994-04-28 George D. Hartman Fibrinogen receptor antagonists
GB9422391D0 (en) 1994-11-05 1995-01-04 Solvay Interox Ltd Oxidation of organosulphur compounds
CA2321153A1 (en) 1998-02-17 1999-08-19 Timothy D. Cushing Anti-viral pyrimidine derivatives
GB9914258D0 (en) * 1999-06-18 1999-08-18 Celltech Therapeutics Ltd Chemical compounds
CA2379585C (en) * 1999-09-30 2006-06-20 James W. Darrow Certain alkylene diamine-substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines
BR0112712A (pt) 2000-07-21 2003-05-20 Syngenta Partcipations Ag Processo para preparação de 4,6-dimetóxi-2-(metilsulfonil)-1,3-pirimidina
PE20020506A1 (es) * 2000-08-22 2002-07-09 Glaxo Group Ltd Derivados de pirazol fusionados como inhibidores de la proteina cinasa
US20030130264A1 (en) 2001-02-16 2003-07-10 Tularik Inc. Methods of using pyrimidine-based antiviral agents
EP1372642A1 (en) * 2001-03-30 2004-01-02 SmithKline Beecham Corporation Use of pyrazolopyridines as therapeutic compounds
DE60210819T2 (de) * 2001-12-17 2007-04-19 Smithkline Beecham Corp. Pyrazolopyridazinderivate
TWI270542B (en) 2002-02-07 2007-01-11 Sumitomo Chemical Co Method for preparing sulfone or sulfoxide compound
JP2006509014A (ja) * 2002-12-04 2006-03-16 ジーン ロジック インコーポレイテッド メラノコルチンレセプターの調節因子
RU2328497C2 (ru) 2003-05-05 2008-07-10 Ф.Хоффманн-Ля Рош Аг Конденсированные производные пиримидина и лекарственное средство, обладающее активностью в отношении crf
KR20070083828A (ko) 2004-10-27 2007-08-24 쉐링 코포레이션 Ｎａｖ１．８의 짧은 간섭 핵산 억제를 위한 조성물 및방법
EP1890703B1 (en) 2005-06-14 2016-05-11 Taigen Biotechnology Pyrimidine compounds as chemokine receptors inhibitors
AU2006266529B2 (en) * 2005-07-06 2010-12-16 Cytiva Bioprocess R&D Ab Method of preparing a separation matrix
TW200800201A (en) * 2005-11-18 2008-01-01 Lilly Co Eli Pyrimidinyl benzothiophene compounds
CN101032483B (zh) * 2006-03-09 2011-05-04 陈德桂 调节雄激素受体活性的乙内酰脲衍生物及其应用
ES2348829T3 (es) * 2006-03-31 2010-12-15 Janssen Pharmaceutica Nv Benzimidazol-2-il-pirimidinas y pirazinas moduladoras del receptor h4 de histamina.
ATE479678T1 (de) * 2006-03-31 2010-09-15 Janssen Pharmaceutica Nv Benzoimidazol-2-yl pyridine als modulatoren des histamin-h4-rezeptors
KR20110022721A (ko) * 2008-06-30 2011-03-07 얀센 파마슈티카 엔.브이. 벤조이미다졸-2-일 피리미딘 유도체의 제조 방법
NZ590170A (en) 2008-06-30 2012-04-27 Janssen Pharmaceutica Nv Process for the preparation of substituted pyrimidine derivatives

Also Published As

Publication number Publication date
KR101675354B1 (ko) 2016-11-11
PE20110163A1 (es) 2011-03-28
TWI498326B (zh) 2015-09-01
HK1215434A1 (zh) 2016-08-26
IL235572A (en) 2016-09-29
US9006432B2 (en) 2015-04-14
US9359327B2 (en) 2016-06-07
DK2310012T3 (da) 2015-03-30
JP5416768B2 (ja) 2014-02-12
US9079883B2 (en) 2015-07-14
WO2010002774A1 (en) 2010-01-07
TW201012810A (en) 2010-04-01
US20130053561A1 (en) 2013-02-28
KR20110023901A (ko) 2011-03-08
EA201170113A1 (ru) 2011-08-30
IL235570A (en) 2016-08-31
IL210214A (en) 2016-07-31
BRPI0913644A2 (pt) 2015-11-24
EP2310012A4 (en) 2012-06-20
US9079882B2 (en) 2015-07-14
ES2538135T3 (es) 2015-06-17
ME02154B (me) 2015-10-20
IL235571A (en) 2016-09-29
UY31949A (es) 2010-01-29
NI201000232A (es) 2011-09-07
EA019361B1 (ru) 2014-03-31
HRP20150576T1 (hr) 2015-09-11
TW201420583A (zh) 2014-06-01
HK1156857A1 (en) 2012-06-22
SV2011003788A (es) 2011-02-08
RS53985B1 (en) 2015-10-30
US9079884B2 (en) 2015-07-14
US20100004450A1 (en) 2010-01-07
JO3043B1 (ar) 2016-09-05
TWI481603B (zh) 2015-04-21
EP2924025A1 (en) 2015-09-30
EP2769721A2 (en) 2014-08-27
HK1214590A1 (zh) 2016-07-29
PT2310012E (pt) 2015-04-02
HUE024949T2 (en) 2016-02-29
MY150601A (en) 2014-01-30
US20140073795A1 (en) 2014-03-13
CA2729733C (en) 2016-10-25
EP2310012B1 (en) 2015-03-04
SI2310012T1 (sl) 2015-06-30
TW201433568A (zh) 2014-09-01
EP2924035A1 (en) 2015-09-30
US20130225816A1 (en) 2013-08-29
US8309720B2 (en) 2012-11-13
AU2009267156B2 (en) 2015-05-28
MX2011000080A (es) 2011-03-02
CY1116134T1 (el) 2017-02-08
US20140066624A1 (en) 2014-03-06
HK1201441A1 (en) 2015-09-04
ZA201100759B (en) 2012-07-25
AU2009267156A1 (en) 2010-01-07
US20140121374A1 (en) 2014-05-01
EP2924023A1 (en) 2015-09-30
CO6341560A2 (es) 2011-11-21
NZ590170A (en) 2012-04-27
PL2310012T3 (pl) 2015-08-31
ECSP11010745A (es) 2011-02-28
EP2310012A1 (en) 2011-04-20
JP2011526910A (ja) 2011-10-20
CN102137672A (zh) 2011-07-27
AR072396A1 (es) 2010-08-25
CN102137672B (zh) 2014-03-26
CA2729733A1 (en) 2010-01-07
IL210214A0 (en) 2011-03-31
EP2769721A3 (en) 2015-04-01

Similar Documents

Publication Publication Date Title
NZ725585A (en) Processes for preparing jak inhibitors and related intermediate compounds
MX2010012298A (es) Activadores de glucocinasa.
MX2011009369A (es) 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
TW200716525A (en) Process for preparation of sulfamide derivatives
MY156546A (en) Process for the regioselective preparation of 1-alkyl-3-haloalkylpyrazole-4-carboxylic acid derivatives
TN2011000673A1 (en) Bace inhibitors
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
TN2012000578A1 (en) Tetrahydro-pyrido-pyrimidine derivatives
TN2011000404A1 (en) Fused pyrimidines
MX2010007490A (es) Preparacion de derivados de sulfamida.
UA106724C2 (uk) Спосіб отримання заміщених піримідинових похідних
EA201270280A1 (ru) Соединения пиримидина в качестве ингибиторов при лечении туберкулеза
WO2010009879A3 (en) Methods for producing paricalcitol
MY157197A (en) Process for the preparation of benzoimidazol-2-yl pyrimidine derivatives
MX2011008825A (es) 3-aminoisoxazolopiridinas sustituidas como moduladores de kcnq2/3.
MX2010010597A (es) Procesos para la preparacion de derivados de dioxina benzofusionados.
MX2011008662A (es) 2-mercapto-3-aminopiridinas sustituidas como moduladores de kcnq2/3.
MX2011009338A (es) 3-amino-2-mercaptoquinolinas sustituidas como moduladores de kcnq2/3.
EA201200820A1 (ru) Способ синтеза промежуточных продуктов, применимых для получения замещенных индазолов и азаиндазолов
TW200736240A (en) Novel processes for the preparation of cyclopropyl-amide derivatives
EA201000180A1 (ru) Способ получения производных пиримидина
MX2011008126A (es) Compuestos de indol sustituidos como moduladores del receptor 1 de bradiquinina.
MX349489B (es) Proceso para la preparación de moduladores del receptor h3 de histamina.
MX2010003056A (es) Polimorfos de valomaciclovir.
MX2010010880A (es) Derivados de 1,3-imidazolidina y su uso en la produccion de carbapenem.